Brendan Smith Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Brendan Smith is Chief Financial Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 5,072 shares of CRSP, which is worth approximately $227,732. The most recent transaction as insider was on Feb 21, 2023, when has been sold 1,392 shares (Common Shares) at a price of $48.26 per share, resulting in proceeds of $67,177. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.07K
0% 3M change
0% 12M change
Total Value Held $227,732

Brendan Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2023
SELL
Payment of exercise price or tax liability
$67,177 $48.26 p/Share
1,392 Reduced 21.53%
5,072 Common Shares
Feb 18 2023
BUY
Exercise of conversion of derivative security
-
3,825 Added 37.18%
6,464 Common Shares
Oct 17 2022
SELL
Payment of exercise price or tax liability
$61,949 $55.76 p/Share
1,111 Reduced 29.63%
2,639 Common Shares
Oct 14 2022
BUY
Exercise of conversion of derivative security
-
3,750 Added 50.0%
3,750 Common Shares

Also insider at

TBIO
Translate Bio, Inc. Healthcare
Chief Financial Officer
BS

Brendan Smith

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP